UTAH MEDICAL PRODUCTS INC (UTMD)
US9174881089 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | N/A | |||
| Cash Equivalents | 93.81M | 92.87M | 75.10M | 61.00M | 51.60M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 3.59M | 3.39M | 5.50M | 5.10M | 4.10M | |||
| Inventories | 9.24M | 9.58M | 8.80M | 6.60M | 6.20M | |||
| Other Current Assets | 510.00K | 428.00K | 500.00K | 500.00K | 300.00K | |||
| Total Current Assets | 107.15M | 106.27M | 89.90M | 73.20M | 62.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 10.27M | 10.55M | 10.20M | 11.10M | 11.30M | |||
| Goodwill | 13.64M | 13.69M | 13.40M | 14.10M | 14.20M | |||
| Intangibles | 4.39M | 4.95M | 10.40M | 17.30M | 24.00M | |||
| Total Non-Current Assets | 28.29M | 29.19M | 34.00M | 42.40M | 49.40M | |||
| TOTAL ASSETS | 135.44M | 135.46M | 123.90M | 115.60M | 111.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 4.48M | 3.61M | 4.40M | 2.90M | 3.00M | |||
| Accounts Payable | 998.00K | 769.00K | 1.20M | 800.00K | 800.00K | |||
| Other Current Liabilities | N/A | 327.00K | 300.00K | 0.00 | 0.00 | |||
| Total Current Liabilities | 5.47M | 4.71M | 6.00M | 3.70M | 3.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | 1.24M | 1.44M | 2.10M | 2.70M | 2.80M | |||
| Other Non-Current Liabilities | 983.00K | 993.00K | 1.60M | 2.10M | 2.30M | |||
| Total Non-Current Liabilities | 2.23M | 2.44M | 3.60M | 4.80M | 5.10M | |||
| TOTAL LIABILITIES | 7.70M | 7.14M | 9.60M | 8.50M | 8.90M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 139.00M | 138.34M | 126.00M | 115.30M | 111.00M | |||
| Additional Paid In Capital | 0.00 | 594.00K | 300.00K | 800.00K | 100.00K | |||
| Common Shares | 36.00K | 36.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -11.29M | -10.66M | -12.00M | -9.10M | -8.30M | |||
| Shares Outstanding | 3.59M | 3.63M | 3.60M | 3.70M | 3.60M | |||
| Tangible Book Value per Share | 30.58 | 30.21 | 25.14 | 20.46 | 17.94 | |||
| Total Shareholders' Equity | 127.74M | 128.31M | 114.30M | 107.10M | 102.80M | |||
| TOTAL LIABILITIES AND EQUITY | 135.44M | 135.46M | 123.90M | 115.60M | 111.70M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 19.57 | 22.56 | 14.98 | 19.78 | 16.39 | |||
| Return On Assets (ROA) | 12.10% | 12.28% | 13.29% | 12.79% | 9.67% | |||
| Return On Equity (ROE) | 12.82% | 12.96% | 14.41% | 13.81% | 10.51% | |||
| Return On Invested Capital (ROIC) | 10.15% | 11.46% | 14.10% | 13.73% | 10.33% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 36.47% | 39.55% | 38.85% | 30.17% | 19.79% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 72.72% | 77.86% | 87.51% | 78.76% | 61.55% | |||
All data in USD